CH Biotech R&D Co., Ltd. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was TWD 749.141 million compared to TWD 717.116 million a year ago. Operating income was TWD 394.861 million compared to TWD 422.117 million a year ago. Net income was TWD 312.114 million compared to TWD 339.126 million a year ago. Basic earnings per share was TWD 3.88 compared to TWD 4.24 a year ago. Diluted earnings per share was TWD 3.83 compared to TWD 4.19 a year ago.